Pain
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Pain is a highly competitive landscape with 140 programs across 75 companies. The most active players are Sanofi, Averitas Pharma, Inc., Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections. 80 therapies are approved with 18 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Sanofi
1 program
Averitas Pharma, Inc.
1 program
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
1 program
COMPASS Pathways
1 program
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
1 program
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
1 program
Pipeline
Programs by Phase
Analysis
Modality Breakdown
95%
Small molecule
134 of 141 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 141 classified programs, each share of the total. Modality classified for 94% of 151 pipeline programs.
Analysis
Trial Status
219
clinical trials
Clinical Trials
Trial Activity
219 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)